Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from BofA

This Analyst Just Upped the Price Target on Snowflake Stock. Here's Why.

Snowflake stock rallied on a bullish note from Bank of America Securities. Here’s why analyst Koji Ikeda sees significant further upside in SNOW shares in 2026.

Dear Google Stock Fans, Mark Your Calendars for May 19

Dear Google Stock Fans, Mark Your Calendars for May 19

Alphabet’s Google I/O event is expected to showcase major Gemini AI upgrades and deeper agentic AI integration.

Erasca Touts 'Eye-Popping' ERAS-0015 Lung Cancer Data, FDA Path at BofA Conference

Erasca (NASDAQ:ERAS) executives said the company sees multiple potential development paths for its RAS-targeting portfolio, highlighting early clinical activity for ERAS-0015 in lung, pancreatic and colorectal cancers during a Bank of America biotech conference session. Jonathan Lim, Erasca’s chair

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Robust Earnings Growth and Innovation Will Help the Marvell Stock Uptrend Keep Going

AMD has disclosed a stake in Marvell Technologies

This Analyst Just Upgraded Akamai Technologies. Here's Why.

Akamai stock rallies as Bank of America raises its price target to $175. Here’s why BofA is constructive on AKAM shares for the remainder of 2026.

Arrowhead Pharmaceuticals Eyes $4B REDEMPLO Opportunity as RNAi Pipeline Readouts Near

Arrowhead Pharmaceuticals (NASDAQ:ARWR) is moving into a more commercial phase while continuing to expand its RNA interference pipeline, Chief Executive Officer Chris Anzalone said during a presentation with BofA pharma and biotech analyst Jason Gerberry at the BofA Annual Healthcare Conference. An

Amylyx Pharmaceuticals Eyes Phase 3 AVEXITIDE Readout as 2027 Launch Comes Into Focus

Amylyx Pharmaceuticals (NASDAQ:AMLX) is preparing for a pivotal Phase 3 readout for AVEXITIDE, its lead asset for post-bariatric hypoglycemia, or PBH, with data from the LUCIDITY trial expected in the third quarter, Co-Chief Executive Officer Joshua Cohen said at the BofA Annual Healthcare Conferenc

inkl

Read news from The Economist, FT, and more,
with one subscription

BridgeBio Pharma Touts Attruby Blockbuster Path, 3 Potential Pipeline Launches

BridgeBio Pharma (NASDAQ:BBIO) executives used a BofA healthcare conference appearance in Las Vegas to reiterate confidence in the commercial trajectory of Attruby and outline expectations for three potential near-term product launches from the company’s late-stage pipeline. Tom Trimarchi, BridgeBi

The Fed is “meaningfully deviating” from one of the most basic rules for fighting inflation, BofA warns

The Fed is “meaningfully deviating” from one of the most basic rules for fighting inflation, BofA warns

Everything you need to know before you reach the office this morning.

US Stock Market: BofA, Goldman push back Fed easing forecasts amid inflation risks

US Stock Market: BofA, Goldman push back Fed easing forecasts amid inflation risks

Major Wall Street brokerages have delayed their expectations for U.S. Federal Reserve rate cuts as high energy prices and a strong labour market keep inflation concerns elevated. BofA now expects no rate cuts in 2026, forecasting easing only in mid-2027, while Goldman Sachs has pushed its expected start of rate…

The Economic Times

Two Americas, one drive-thru: Welcome to fast food's contradictory, split-screen economy

Two Americas, one drive-thru: Welcome to fast food's contradictory, split-screen economy

From McDonald's to Papa John's to Wingstop, Q1 earnings are painting a portrait of a nation sorting itself into winners and losers at the drive-thru window.

BofA throws cold water on AI apocalypse panic: 60% of today's jobs didn't exist in 1940

BofA throws cold water on AI apocalypse panic: 60% of today's jobs didn't exist in 1940

AI will reshape 840 million jobs, BofA says. That’s not the same as destroying them.

Should You Buy the Dip in Nvidia Stock Today?

Should You Buy the Dip in Nvidia Stock Today?

Nvidia stock is sinking as Google and Amazon tout in-house chips on thier Q1 earnings calls. BofA still recommends buying the dip in NVDA shares today.

Bank of America's 18,000 financial advisors just got a new AI tool as the company posts a record quarter

Bank of America's 18,000 financial advisors just got a new AI tool as the company posts a record quarter

A new AI tool for financial advisors is one sign of how Bank of America is weaving artificial intelligence into its business model.

Get all your
news in one place.

100's of premium titles.
One news app.

Macquarie Is Pounding the Table on CoreWeave Stock with a New ‘Outperform’ Rating. Should You Buy Here?

Macquarie upgraded CoreWeave, citing its new deals, including an agreement with Anthropic.

On Semiconductor Pops on Analyst Upgrade. Should You Buy ON Stock Here?

On Semiconductor stock gains on a bullish BofA research note. Here’s why analyst Vivek Arya recommends buying ON shares at current levels.

Bank of America Says Marvell and AMD Are 2 Top ‘AI Compute’ Stocks to Buy Now

BofA sees Marvell and AMD well positioned as AI demand drives the next wave of chip growth.

Bank of America Wants You to Buy the Dip in These 2 Picks-and-Shovels AI Stocks

Bank of America just upgraded its semiconductor outlook and flagged Cadence and Synopsys as top AI "picks-and-shovels" buys. Here's what investors need to know.

Get all your
news in one place.

100's of premium titles.
One news app.

Robotaxis Are Expensive, and Investors Are Now Punishing Pony AI Stock. Have They Gone Too Far?

Pony stock sinks as Q4 revenue comes in down 18% on a year-over-year basis. BofA analyst explains why PONY shares are still worth buying on the post-earnings dip.

Bank of America Says Oracle Stock Can Gain More Than 30% from Here. Why?

Bank of America reinstated coverage of ORCL with a $200 price target.

Bank of America Is Betting That Nebius Stock Still Has 30% Upside Potential. Should You Buy It Here?

Nebius stock has surged nearly 300% in a year as investors bet on explosive AI-cloud growth and major contracts with Meta and Microsoft.

Gen Z finally had room to breathe. Now Trump's 26% gas price hike has them suffocating

Gen Z and millennials had finally caught up—and passed—boomers in spending growth in 2025. Then came war in Iran.

Bank of America Still Loves Nvidia Stock After GTC 2026. Should You?

Nvidia stock closed in the red today despite bullish updates at its annual GTC conference. Bank of America recommends buying NVDA shares on the dip.

3 Key Things Analysts Are Watching for Nvidia Stock Before GTC 2026

Bank of America maintains its bullish view on NVDA ahead of GTC next week. Here's what to watch.

More people will own a humanoid robot than a car by 2060, BofA predicts

An aging workforce, a labor shortage, and a capital surge are quietly building the foundation for the biggest consumer technology wave since the smartphone.

1 2 3 4 5

People

William Stanley Jevons

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

the Federal Reserve

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

373,994 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play